© 1995 Oxford University Press
OTHER |
Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development
Center for the Study of Nervous System Injury, Departments of Neurxsxsology, Pediatrics and Genetics, Washington University School of Medicine St Louis, MO, USA
*To whom correspondence should be addressed
Received November 9, 1994; Revised December 22, 1994; Accepted December 22, 1994
The neurofibromatosis 2 (NF2) gene product, merlin, encodes a 595 amino acid protein with sequence similarity to a family of proteins linking cell membrane proteins to the cytoskeleton. Two isoforms of merlin have been described which differ by the presence (type 2 merlin) or absence (type 1 merlin) of exon 16 sequences inserted into the extreme carboxyl terminus of the protein. To determine the role of this important negative growth regulator during normal embryonic development, the expression of these two merlin isoforms was examined at representative stages of rat embryogenesis and in adult tissues. Partial sequence analysis of the rat merlin gene demonstrated striking amino acid identity to the published mouse and human merlin gene sequences. In situ hybridization and RTPCR analyses demonstrated that rat merlin is widely expressed during embryogenesis and early postnatal life in most tissues but becomes restricted to the brainstem, cerebellum, dorsal root ganglia, spinal cord, adrenal gland and testis in adult animals. The elucidation of the pattern of merlin gene expression in adult and embryonic tissues provides the foundations for future studies aimed at determining the function(s) of this protein during cell differentiation and embryonic development.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. O. Hanemann Magic but treatable? Tumours due to loss of Merlin Brain, March 1, 2008; 131(3): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gronholm, L. Vossebein, C. R. Carlson, J. Kuja-Panula, T. Teesalu, K. Alfthan, A. Vaheri, H. Rauvala, F. W. Herberg, K. Tasken, et al. Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RI{beta} Subunit of Protein Kinase A J. Biol. Chem., October 17, 2003; 278(42): 41167 - 41172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sainio, J. Jaaskelainen, H. Pihlaja, and O. Carpen Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus Neurology, March 14, 2000; 54(5): 1132 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. den Bakker, K. J. Vissers, A. C. Molijn, J. M. Kros, E. C. Zwarthoff, and T. H. van der Kwast Expression of the Neurofibromatosis Type 2 Gene in Human Tissues J. Histochem. Cytochem., November 1, 1999; 47(11): 1471 - 1480. [Abstract] [Full Text] |
||||
![]() |
R. J. Shaw, A. I. McClatchey, and T. Jacks Regulation of the Neurofibromatosis Type 2 Tumor Suppressor Protein, Merlin, by Adhesion and Growth Arrest Stimuli J. Biol. Chem., March 27, 1998; 273(13): 7757 - 7764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jannatipour, P. Dion, S. Khan, H. Jindal, X. Fan, J. Laganiere, A. H. Chishti, and G. A. Rouleau Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains J. Biol. Chem., August 24, 2001; 276(35): 33093 - 33100. [Abstract] [Full Text] [PDF] |
||||



